CCL2 and Familial prostate cancer: However, Tas et al. report that while gastric cancer patients who responded to chemotherapy had lower serum CCL2 than non-responders, there was no association between serum CCL2 and any measured clinical variables; Tsuar et al. report that elevated serum CCL2 was negatively correlated with PSA value in prostate cancer patients; and Monti et al. report that elevated serum CCL2 was associated with increased survival in pancreas cancer patients.